PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trial.

Annals of hematology

Volumn 83 Suppl 1, Issue , 2004, Pages

  Stone, R M ^a   De Angelo, J ^a   Galinsky, I ^a   Estey, E ^a   Klimek, V ^a   Grandin, W ^a   Lebwohl, D ^a   Yap, A ^a   Cohen, P ^a   Fox, E ^a   Neuberg, D ^a   Clark, J ^a   Gilliland, D G ^a   Griffin, J D ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; ENZYME INHIBITOR; FLT3 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLAST CELL CRISIS; CLINICAL TRIAL; DRUG ANTAGONISM; HUMAN; PATHOLOGY; PHASE 2 CLINICAL TRIAL;

BLAST CRISIS; ENZYME INHIBITORS; FMS-LIKE TYROSINE KINASE 3; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 3042581224     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)